These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11418119)

  • 21. Control of gene expression in plant cells using a 434:VP16 chimeric protein.
    Wilde RJ; Cooke SE; Brammar WJ; Schuch W
    Plant Mol Biol; 1994 Jan; 24(2):381-8. PubMed ID: 8111039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic activation of transcription by the mutant and wild-type minimal transcriptional activation domain of VP16.
    Ghosh S; Toth C; Peterlin BM; Seto E
    J Biol Chem; 1996 Apr; 271(17):9911-8. PubMed ID: 8626627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The strength of acidic activation domains correlates with their affinity for both transcriptional and non-transcriptional proteins.
    Melcher K
    J Mol Biol; 2000 Sep; 301(5):1097-112. PubMed ID: 10966808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA; Altmann M; Edwards DP
    Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artificial oncoproteins: modified versions of the yeast bZip protein GCN4 induce cellular transformation.
    Nishizawa M; Fu SL; Kataoka K; Vogt PK
    Oncogene; 2003 Sep; 22(39):7931-41. PubMed ID: 12970741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A trans-acting peptide activates the yeast a1 repressor by raising its DNA-binding affinity.
    Stark MR; Escher D; Johnson AD
    EMBO J; 1999 Mar; 18(6):1621-9. PubMed ID: 10075932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of a 434:VP16 chimeric activator leads to high-level activation of gene expression in stable transformants of Arabidopsis.
    Storgaard M; Didion T; Okkels F; Nielse KK
    Transgenic Res; 2002 Apr; 11(2):151-9. PubMed ID: 12054349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation of the VP16 transcriptional activator protein during herpes simplex virus infection and mutational analysis of putative phosphorylation sites.
    Ottosen S; Herrera FJ; Doroghazi JR; Hull A; Mittal S; Lane WS; Triezenberg SJ
    Virology; 2006 Feb; 345(2):468-81. PubMed ID: 16297954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette.
    Hofmann A; Nolan GP; Blau HM
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5185-90. PubMed ID: 8643550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PDX-1 activation domain provides specific functions necessary for transcriptional stimulation in pancreatic beta-cells.
    Peshavaria M; Cissell MA; Henderson E; Petersen HV; Stein R
    Mol Endocrinol; 2000 Dec; 14(12):1907-17. PubMed ID: 11117522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single amino acid substitution in herpes simplex virus type 1 VP16 inhibits binding to the virion host shutoff protein and is incompatible with virus growth.
    Knez J; Bilan PT; Capone JP
    J Virol; 2003 Mar; 77(5):2892-902. PubMed ID: 12584313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.
    Popova B; Bilan P; Xiao P; Faught M; Capone JP
    Virology; 1995 May; 209(1):19-28. PubMed ID: 7747469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation domains for controlling plant gene expression using designed transcription factors.
    Li J; Blue R; Zeitler B; Strange TL; Pearl JR; Huizinga DH; Evans S; Gregory PD; Urnov FD; Petolino JF
    Plant Biotechnol J; 2013 Aug; 11(6):671-80. PubMed ID: 23521778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian two-hybrid system: a complementary approach to the yeast two-hybrid system.
    Luo Y; Batalao A; Zhou H; Zhu L
    Biotechniques; 1997 Feb; 22(2):350-2. PubMed ID: 9043710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA recognition by the herpes simplex virus transactivator VP16: a novel DNA-binding structure.
    Babb R; Huang CC; Aufiero DJ; Herr W
    Mol Cell Biol; 2001 Jul; 21(14):4700-12. PubMed ID: 11416146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical amino acids in the transcriptional activation domain of the herpesvirus protein VP16 are solvent-exposed in highly mobile protein segments. An intrinsic fluorescence study.
    Shen F; Triezenberg SJ; Hensley P; Porter D; Knutson JR
    J Biol Chem; 1996 Mar; 271(9):4819-26. PubMed ID: 8617751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
    Ghosh S; Selby MJ; Peterlin BM
    J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interphase movements of a DNA chromosome region modulated by VP16 transcriptional activator.
    Tumbar T; Belmont AS
    Nat Cell Biol; 2001 Feb; 3(2):134-9. PubMed ID: 11175745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The VP16 activation domain establishes an active mediator lacking CDK8 in vivo.
    Uhlmann T; Boeing S; Lehmbacher M; Meisterernst M
    J Biol Chem; 2007 Jan; 282(4):2163-73. PubMed ID: 17135252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intramolecular control of transcriptional activity by the NK2-specific domain in NK-2 homeodomain proteins.
    Watada H; Mirmira RG; Kalamaras J; German MS
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9443-8. PubMed ID: 10944215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.